Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-024131
Filing Date
2025-03-17
Accepted
2025-03-17 06:07:20
Documents
3
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm258947d2_6k.htm 6-K 10694
2 EXHIBIT 99.1 tm258947d2_ex99-1.htm EX-99.1 4408
3 GRAPHIC tm258947d2_ex99-1img001.jpg GRAPHIC 3036
  Complete submission text file 0001104659-25-024131.txt   20489
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41359 | Film No.: 25742240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)